Crossmark

Intensity-modulated proton therapy for patients with unresectable giant (≥ 10 cm) hepatocellular carcinoma: a retrospective analysis from two high-volume centers

Crossref DOI link: https://doi.org/10.1007/s11604-026-01947-1

Published Online: 2026-02-05

Published Print: 2026-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cheng, Jen-Yu

Wang, Yu-Ming

Chen, Yen-Hao

Liu, Chieh-Min

Huang, Eng-Yen

Ou, Hsin-You

Hu, Tsung-Hui

Lu, Sheng-Nan

Wang, Chih-Chi

Tseng, Jeng-Hwei

Lin, Shi-Ming

Lin, Chen-Chun

Chan, Kun-Ming

Chen, Wan-Yu

Huang, Bing-Shen https://orcid.org/0000-0002-0477-448X
Funding

Funding for this research was provided by:

Chang Gung Medical Foundation (CMRPG8N0661)

Chang Gung Medical Foundation (CMRPG3M1501)
License Information

Text and Data Mining valid from 2026-02-05

Version of Record valid from 2026-02-05
More Information

Article History

Received: 7 August 2025

Accepted: 4 January 2026

First Online: 5 February 2026

Declarations

:

: The authors declare that they have no competing interests.

: This study was approved by the institutional review board (IRB) of the Chang Gung Medical Foundation (reference number 202400637B0).

Document is current

Any future updates will be listed below